全文获取类型
收费全文 | 8749篇 |
免费 | 526篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 126篇 |
儿科学 | 276篇 |
妇产科学 | 263篇 |
基础医学 | 905篇 |
口腔科学 | 139篇 |
临床医学 | 786篇 |
内科学 | 2285篇 |
皮肤病学 | 82篇 |
神经病学 | 911篇 |
特种医学 | 338篇 |
外科学 | 941篇 |
综合类 | 93篇 |
一般理论 | 6篇 |
预防医学 | 988篇 |
眼科学 | 158篇 |
药学 | 570篇 |
中国医学 | 2篇 |
肿瘤学 | 432篇 |
出版年
2024年 | 7篇 |
2023年 | 35篇 |
2022年 | 59篇 |
2021年 | 178篇 |
2020年 | 83篇 |
2019年 | 169篇 |
2018年 | 194篇 |
2017年 | 163篇 |
2016年 | 147篇 |
2015年 | 172篇 |
2014年 | 281篇 |
2013年 | 391篇 |
2012年 | 633篇 |
2011年 | 695篇 |
2010年 | 383篇 |
2009年 | 376篇 |
2008年 | 575篇 |
2007年 | 691篇 |
2006年 | 649篇 |
2005年 | 616篇 |
2004年 | 584篇 |
2003年 | 540篇 |
2002年 | 475篇 |
2001年 | 106篇 |
2000年 | 71篇 |
1999年 | 81篇 |
1998年 | 106篇 |
1997年 | 80篇 |
1996年 | 63篇 |
1995年 | 71篇 |
1994年 | 49篇 |
1993年 | 50篇 |
1992年 | 61篇 |
1991年 | 38篇 |
1990年 | 45篇 |
1989年 | 67篇 |
1988年 | 40篇 |
1987年 | 28篇 |
1986年 | 28篇 |
1985年 | 19篇 |
1984年 | 34篇 |
1983年 | 21篇 |
1982年 | 26篇 |
1981年 | 25篇 |
1980年 | 18篇 |
1979年 | 11篇 |
1978年 | 14篇 |
1977年 | 11篇 |
1976年 | 9篇 |
1971年 | 6篇 |
排序方式: 共有9301条查询结果,搜索用时 15 毫秒
161.
Pig kidney graft survival in a baboon for 136 days: longest life‐supporting organ graft survival to date 下载免费PDF全文
Martin Wijkstrom Huidong Zhou Jagjit Singh Hidetaka Hara Mohamed Ezzelarab Cassandra Long Edwin Klein Robert Wagner Carol Phelps David Ayares Ron Shapiro Abhinav Humar David K. C. Cooper 《Xenotransplantation》2015,22(4):302-309
The longest survival of a non‐human primate with a life‐supporting kidney graft to date has been 90 days, although graft survival > 30 days has been unusual. A baboon received a kidney graft from an α‐1,3‐galactosyltransferase gene‐knockout pig transgenic for two human complement‐regulatory proteins and three human coagulation‐regulatory proteins (although only one was expressed in the kidney). Immunosuppressive therapy was with ATG+anti‐CD20mAb (induction) and anti‐CD40mAb+rapamycin+corticosteroids (maintenance). Anti‐TNF‐α and anti‐IL‐6R were administered. The baboon survived 136 days with a generally stable serum creatinine (0.6 to 1.6 mg/dl) until termination. No features of a consumptive coagulopathy (e.g., thrombocytopenia, decreased fibrinogen) or of a protein‐losing nephropathy were observed. There was no evidence of an elicited anti‐pig antibody response. Death was from septic shock (Myroides spp). Histology of a biopsy on day 103 was normal, but by day 136, the kidney showed features of glomerular enlargement, thrombi, and mesangial expansion. The combination of (i) a graft from a specific genetically engineered pig, (ii) an effective immunosuppressive regimen, and (iii) anti‐inflammatory agents prevented immune injury and a protein‐losing nephropathy, and delayed coagulation dysfunction. This outcome encourages us that clinical renal xenotransplantation may become a reality. 相似文献
162.
163.
Ortenberg R Gon S Porat A Beckwith J 《Proceedings of the National Academy of Sciences of the United States of America》2004,101(19):7439-7444
A strain of Escherichia coli missing three members of the thioredoxin superfamily, thioredoxins 1 and 2 and glutaredoxin 1, is unable to grow, a phenotype presumed to be due to the inability of cells to reduce the essential enzyme ribonucleotide reductase. Two classes of mutations can restore growth to such a strain. First, we have isolated a collection of mutations in the gene for the protein glutaredoxin 3 that suppress the growth defect. Remarkably, all eight independent mutations alter the same amino acid, methionine-43, changing it to valine, isoleucine, or leucine. From the position of the amino acid changes and their effects, we propose that these alterations change the protein so that its properties are closer to those of glutaredoxin 1. The second means of suppressing the growth defects of the multiply mutant strain was by mutations in the DNA replication genes, dnaA and dnaN. These mutations substantially increase the expression of ribonucleotide reductase, most likely by altering the interaction of the regulatory protein DnaA with the ribonucleotide reductase promoter. Our results suggest that this increase in the concentration of ribonucleotide reductase in the cell allows more effective interaction with glutaredoxin 3, thus restoring an effective pool of deoxyribonucleotides. Our studies present direct evidence that ribonucleotide reductase is the only essential enzyme that requires the three reductive proteins missing in our strains. Our results also suggest an unexpected regulatory interaction between the DnaA and DnaN proteins. 相似文献
164.
165.
Biagini E Elhendy A Bax JJ Rizzello V Schinkel AF van Domburg RT Kertai MD Krenning BJ Bountioukos M Rapezzi C Branzi A Simoons ML Poldermans D 《Journal of the American College of Cardiology》2005,45(1):93-97
OBJECTIVES: The aim of this study was to investigate the effects of gender on long-term prognosis of patients undergoing dobutamine stress echocardiography (DSE). BACKGROUND: Gender differences in the predictors of outcome among patients with known or suspected coronary artery disease undergoing DSE have not been adequately studied. METHODS: We studied 2,276 men and 1,105 women with known or suspected coronary artery disease who underwent DSE. Follow-up events were cardiac death and nonfatal myocardial infarction (MI). RESULTS: Dobutamine stress echocardiography was normal in 687 men (30%) and 483 women (44%) (p <0.0001). Ischemia on DSE was present in 1,194 men (52%) and 416 women (38%) (p <0.001). During a mean follow-up of 7 +/- 3.4 years, there were 894 (26%) deaths (442 attributed to cardiac causes) and 145 (4%) nonfatal MIs. The annual cardiac event rate was 2.5% in men and 1.2% in women with normal DSE. Independent predictors of cardiac events in patients with normal DSE using a Cox proportional hazards regression analysis were male gender (hazard ratio [HR]: 1.7 [range 1.1 to 2.8]), age (HR: 1.02 [range 1.01 to 1.04]), history of heart failure (HR: 3.4 [range 1.5 to 7.9]), previous MI (HR: 1.7 [range 1.1 to 2.8]), and diabetes (HR: 2.4 [range 1.3 to 4.5]). Independent predictors of cardiac events in patients with an abnormal DSE were age (HR: 1.03 [range 1.02 to 1.04]), history of heart failure (HR: 1.7 [range 1.3 to 2.1]), diabetes (HR: 1.4 [range 1.1 to 1.8]), heart rate at rest (HR: 2.8 [range 1.4 to 5.8]), wall motion abnormalities at rest (HR: 1.06 [range 1.04 to 1.09]), and ischemia on DSE (HR: 1.04 [range 1.02 to 1.07]). Myocardial ischemia was an independent predictor of cardiac events in both men and women. CONCLUSIONS: Dobutamine stress echocardiography provides independent prognostic information in both men and women. In patients with normal DSE, gender is independently associated with cardiac events. The outcome of patients with abnormal DSE is not related to gender, after adjusting for stress echocardiographic abnormalities. 相似文献
166.
167.
Aliza Hussain Wensheng Sun Anita Deswal James A. de Lemos John W. McEvoy Ron C. Hoogeveen Kunihiro Matsushita David Aguilar Biykem Bozkurt Salim S. Virani Amil M. Shah Elizabeth Selvin Chiadi Ndumule Christie M. Ballantyne Vijay Nambi 《Journal of the American College of Cardiology》2021,77(5):559-571
BackgroundAlthough intensive blood pressure reduction has cardiovascular benefits, the absolute benefit is greater in those at higher cardiovascular disease (CVD) risk.ObjectivesThis study examined whether N-terminal pro–B-type natriuretic peptide (NT-proBNP) helps identify subjects at higher risk for CVD events across systolic blood pressure (SBP), diastolic blood pressure (DBP), or pulse pressure (PP) categories.MethodsParticipants from the ARIC (Atherosclerosis Risk In Communities) study visit 4 (1996 to 98) were grouped according to SBP, DBP, or PP categories and further stratified by NT-proBNP categories. Cox regression models were used to estimate hazard ratios for incident CVD (coronary heart disease, ischemic stroke, or heart failure hospitalization) and mortality across combined NT-proBNP and/or BP categories, adjusting for CVD risk factors.ResultsThere were 9,309 participants (age: 62.6 ± 5.6 years; 58.3% women) with 2,416 CVD events over a median follow-up of 16.7 years. Within each SBP, DBP, or PP category, a higher category of NT-proBNP (100 to <300 or 300 pg/ml, compared with NT-proBNP <100 pg/ml) was associated with a graded increased risk for CVD events and mortality. Participants with SBP 130 to 139 mm Hg but NT-proBNP ≥300 pg/ml had a hazards ratio of 3.4 for CVD (95% confidence interval: 2.44 to 4.77) compared with a NT-proBNP of <100 pg/ml and SBP of 140 to 149 mm Hg.ConclusionsElevated NT-proBNP is independently associated with CVD and mortality across SBP, DBP, and PP categories and helps identify subjects at the highest risk. Participants with stage 1 hypertension but elevated NT-proBNP had greater cardiovascular risk compared with those with stage 2 SBP but lower NT-proBNP. Future studies are needed to evaluate use of biomarker-based strategies for CVD risk assessment to assist with initiation or intensification of BP treatment. 相似文献
168.
169.
170.